VITALITY BIOPHARMA INC (OTCMKTS:VBIO) Sellers Decreased Their Shorts By 20.55%

June 27, 2018 - By Mark Williams

VITALITY BIOPHARMA INC (OTCMKTS:VBIO) showed a decrease of 20.55% in short interest. FINRA published in June VBIO’s total 183,600 short interest. The 231,100 previous shares are down with 20.55%. Former VBIO’s position will need 2 days to restore. It has 106,500 average volume. VITALITY BIOPHARMA INC’s short interest float is 0.99%.

Ticker’s shares touched $1.55 during the last trading session after 5.49% change.Currently Vitality Biopharma, Inc. is after 0.00% change in last June 27, 2017. VBIO has also 90,731 shares volume. VBIO underperformed the S&P500 by 12.57%.

Vitality Biopharma, Inc. focuses on the development of cannabinoid pharmaceuticals for the treatment of neurological and inflammatory disorders in the United States.The firm is valued at $34.87 million. The Company’s products in pipeline include VITA-100, an oral cannabinoid formulation that is used for the acute treatment of inflammatory bowel disease and narcotic bowel syndrome; and VITA-210, a cannabinoid formulation, which is in preclinical studies for use in the chronic treatment of neuropathic pain, irritable bowel syndrome, muscle spasticity in multiple sclerosis, and opioid-induced bowel dysfunction.Currently it has negative earnings. The firm was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: